Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and
[Cancer Treatment and Research] Ovarian Cancer Volume 149 || Novel Therapeutic Targets
β Scribed by Stack, M. Sharon; Fishman, David A.
- Book ID
- 121506704
- Publisher
- Springer US
- Year
- 2009
- Tongue
- English
- Weight
- 437 KB
- Edition
- 2
- Category
- Article
- ISBN
- 0387980946
No coin nor oath required. For personal study only.
β¦ Synopsis
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and metastatic dissemination require a complex cascade of interrelated genetic, molecular, and biochemical events that regulate the neoplastic transition of normal ovarian surface epithelium. This updated second edition includes exciting new advances in ovarian cancer detection and treatment and provides an analysis of current research into aspects of malignant transformation, growth control, and metastasis. A more detailed understanding of these processes may ultimately translate into the development of novel approaches for the detection and control of ovarian cancer.
π SIMILAR VOLUMES
Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of effective tumor-specific therapeutics. Ovarian carcinogenesis, invasion, and
## Abstract Ovarian cancer, the most aggressive gynecologic cancer, is the foremost cause of death from gynecologic malignancies in the developed world. Two primary reasons explain its aggressive behavior: most patients present with advanced disease at diagnosis, and die of recurrences from disease
The **Advances in Cancer Research** series provides invaluable information on the exciting and fast-moving field of cancer research. A very special event the Nobel Minisymposium, βMolecular Oncology β From Bench to Bedside,Β held at the Karolinska Instituet, in Stockholm, Sweden, was marked the cele